Search

SUMMARY Combined inference for heterogeneous high-dimensional data is critical in modern biology, where clinical and various kinds of molecular data may be available from a single study. Classical genetic association studies regress a single clinical outcome on many genetic variants one by one, but there is an increasing demand for joint analysis of many molecular outcomes and genetic variants in order to unravel functional interactions. Unfortunately, most existing approaches to joint modeling are either too simplistic to be powerful or are impracticable for computational reasons. Inspired by Richardson and others (2010, Bayesian Statistics 9), we consider a sparse multivariate regression model that allows simultaneous selection of predictors and associated responses. As Markov chain Monte Carlo (MCMC) inference on such models can be prohibitively slow when the number of genetic variants exceeds a few thousand, we propose a variational inference approach which produces posterior information very close to that of MCMC inference, at a much reduced computational cost. Extensive numerical experiments show that our approach outperforms popular variable selection methods and tailored Bayesian procedures, dealing within hours with problems involving hundreds of thousands of genetic variants and tens to hundreds of clinical or molecular outcomes.

Genetic association studies have become increasingly important in understanding the molecular bases of complex human traits. The specific analysis of intermediate molecular traits, via quantitative trait locus (QTL) studies, has recently received much attention, prompted by the advance of high-throughput technologies for quantifying gene, protein and metabolite levels. Of great interest is the detection of weak trans-regulatory effects between a genetic variant and a distal gene product. In particular, hotspot genetic variants, which remotely control the levels of many molecular outcomes, may initiate decisive functional mechanisms underlying disease endpoints. This thesis proposes a Bayesian hierarchical approach for joint analysis of QTL data on a genome-wide scale. We consider a series of parallel sparse regressions combined in a hierarchical manner to flexibly accommodate high-dimensional responses (molecular levels) and predictors (genetic variants), and we present new methods for large-scale inference. Existing approaches have limitations. Conventional marginal screening does not account for local dependencies and association patterns common to multiple outcomes and genetic variants, whereas joint modelling approaches are restricted to relatively small datasets by computational constraints. Our novel framework allows information-sharing across outcomes and variants, thereby enhancing the detection of weak trans and hotspot effects, and implements tailored variational inference procedures that allow simultaneous analysis of data for an entire QTL study, comprising hundreds of thousands of predictors, and thousands of responses and samples. The present work also describes extensions to leverage spatial and functional information on the genetic variants, for example, using predictor-level covariates such as epigenomic marks. Moreover, we augment variational inference with simulated annealing and parallel expectation-maximisation schemes in order to enhance exploration of highly multimodal spaces and allow efficient empirical Bayes estimation. Our methods, publicly available as packages implemented in R and C++, are extensively assessed in realistic simulations. Their advantages are illustrated in several QTL applications, including a large-scale proteomic QTL study on two clinical cohorts that highlights novel candidate biomarkers for metabolic disorders.